Results 321 to 330 of about 293,114 (367)

Acute mitral regurgitation

Heart, 2019
The diagnosis of acute mitral regurgitation (MR) is often missed or delayed because the clinical presentation is substantially different from that in patients with chronic MR.
N. Watanabe
semanticscholar   +4 more sources

Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation.

New England Journal of Medicine, 2023
BACKGROUND Data from a 5-year follow-up of outcomes after transcatheter edge-to-edge repair of severe mitral regurgitation, as compared with outcomes after maximal doses of guideline-directed medical therapy alone, in patients with heart failure are now ...
G. Stone, W. Abraham, J. Lindenfeld, S. Kar, P. Grayburn, D. Lim, Jacob M. Mishell, B. Whisenant, M. Rinaldi, S. Kapadia, V. Rajagopal, I. Sarembock, A. Brieke, S. Marx, D. Cohen, F. Asch, M. Mack   +16 more
semanticscholar   +1 more source

Transcatheter Mitral Valve Repair for Degenerative Mitral Regurgitation.

Journal of the American Medical Association (JAMA), 2023
Importance There are limited data on the outcomes of transcatheter edge-to-edge mitral valve repair for degenerative mitral regurgitation (MR) in a real-world setting.
R. Makkar, J. Chikwe, T. Chakravarty, Qiudong Chen, P. O'Gara, M. Gillinov, M. Mack, A. Vekstein, D. Patel, A. Stebbins, A. Gelijns, Moody Makar, Deepak L. Bhatt, S. Kapadia, S. Vemulapalli, M. Leon   +15 more
semanticscholar   +1 more source

Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC‐HFA Heart Failure Long‐Term Registry

European Journal of Heart Failure, 2023
Mitral regurgitation (MR) and tricuspid regurgitation (TR) are common in patients with heart failure (HF). The aim of this study was to investigate prevalence, clinical characteristics and outcomes of patients with or without isolated or combined MR and ...
M. Adamo, O. Chioncel, L. Benson, B. Shahim, M. Crespo-Leiro, S. Anker, A. Coats, G. Filippatos, M. Lainščak, T. McDonagh, A. Mebazaa, Massimo F Piepoli, Giuseppe M C Rosano, F. Ruschitzka, G. Savarese, P. Seferovic, A. Shahim, B. Popescu, B. Iung, M. Volterrani, A. Maggioni, M. Metra, L. Lund   +22 more
semanticscholar   +1 more source

Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry)

Catheterization and cardiovascular interventions, 2021
To assess outcomes in patients with acute mitral regurgitation (MR) following acute myocardial infarction (AMI) who received percutaneous mitral valve repair (PMVR) with the MitraClip device and to compare outcomes of patients who developed cardiogenic ...
R. Estévez-Loureiro, M. Shuvy, M. Taramasso, T. Benito-González, P. Denti, D. Arzamendi, M. Adamo, X. Freixa, P. Villablanca, Lian Krivoshei, N. Fam, K. Spargias, A. Czarnecki, D. Haberman, Y. Agmon, D. Sudarsky, I. Pascual, Vlasis N. Ninios, Salvatore Scianna, Igal Moaraf, D. Schiavi, M. Chrissoheris, R. Beeri, A. Kerner, E. Fernández-Peregrina, Mattia Di Pasquale, A. Regueiro, L. Poles, A. Iñíguez-Romo, F. Fernández-Vázquez, F. Maisano   +30 more
semanticscholar   +1 more source

Mitral regurgitation

The Lancet, 2009
Mitral regurgitation affects more than 2 million people in the USA. The main causes are classified as degenerative (with valve prolapse) and ischaemic (ie, due to consequences of coronary disease) in developed countries, or rheumatic (in developing countries).
Maurice, Enriquez-Sarano, Cary W, Akins, Alec, Vahanian   +2 more
openaire   +4 more sources

Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation

Heart, 2021
Objective The study aims were (1) to identify the community prevalence of moderate or greater mitral or tricuspid regurgitation (MR/TR), (2) to compare subjects identified by population screening with those with known valvular heart disease (VHD), (3) to
T. Cahill, A. Prothero, Joanna Wilson, A. Kennedy, Jacob Brubert, Megan Masters, J. Newton, S. Dawkins, M. Enriquez-Sarano, B. Prendergast, S. Myerson   +10 more
semanticscholar   +1 more source

New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation.

JAMA cardiology, 2020
Importance Traditionally, physicians distinguished between mitral regurgitation (MR) as a determinant of outcomes and MR as a biomarker of left-ventricular (LV) dysfunction by designating the lesions as primary or secondary, respectively.
M. Packer, P. Grayburn
semanticscholar   +1 more source

Mitral regurgitation

Current Treatment Options in Cardiovascular Medicine, 2000
Chronic severe mitral regurgitation is a surgically correctable disorder. Advances in cardiac surgery (including mitral valve repair and less invasive operations), a low postoperative complication rate, and improved long-term prognosis have reduced the threshold for surgical referral. Choosing the optimal timing for surgery remains the cardinal problem.
William J. Stewart, Craig R. Asher
openaire   +3 more sources

Degenerative mitral regurgitation

Current Opinion in Cardiology, 2020
Purpose of review Degenerative mitral regurgitation (DMR) continues to be an important cause of morbidity and mortality with surgical mitral valve repair remaining the gold standard for the treatment of severe disease. The purpose of this review is to summarize recent advances in the understanding of DMR as well as the progress
Soulat-Dufour, Laurie, Addetia, Karima
openaire   +4 more sources